Dr. Haripriya Parapparambil Surendran

About

Enthusiastic post doctoral fellow in immuno-oncology with a background in clinical pharmacology, specializing in Neuro-oncology, neuropsychology, neuro pharmacology, and therapeutic drug monitoring. Proficient in conducting systematic reviews and meta-analyses, as well as skilled in SPSS data analysis, Rev Man and R programming.

Employment

• Basavatarakam Indo American Cancer Hospital and Research Institute Post-Doctoral Fellow
  2026 - Present
• Amrita Institute of Medical Sciences and Research Centre Ph D Scholar
  2021 - Present
• Amrita College of Pharmaceutical Sciences Research Assistant
  2021 - Present

Education

• Amrita Institute of Medical Sciences and Research Centre PhD
  2021 - 2025

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Neuropsychological functioning and emotional processing in acoustic schwannoma: Insights from an Indian cohort
  Applied Neuropsychology: Adult 2026 DOI: 10.1080/23279095.2026.2669348
  +Save
• Concordance of Receptor Expression Status in the Primary Breast Tumor and in Breast Cancer Metastasized into the Brain: Analysis from an Indian Cohort Prospective Study (CTRI/2022/01/039599)
  Indian Journal of Surgical Oncology 2025 DOI: 10.1007/s13193-025-02427-0
  +Save
• Optimizing memantine dose, by TDM, for preserving cognitive function in brain metastatic patients undergoing radiotherapy CTRI/2024/04/066217
  European Journal of Pharmacology 2025 DOI: 10.1016/j.ejphar.2025.177778
  +Save
• Memantine in radiation-induced cognitive dysfunction in brain metastases: A double-blinded, randomized, placebo-controlled trial (CTRI/2022/01/039599).
  Journal of Clinical Oncology 2025 DOI: 10.1200/jco.2025.43.16_suppl.2036
  +Save
• Efficacy of Hippocampal Avoidance Whole Brain Radiotherapy to Preserve the Cognitive Functions among Brain Metastasis Patients: Systematic Review and Meta-analysis
  Neurology India 2025 DOI: 10.4103/neurol-india.neurol-india-d-24-00727
  +Save
• Tuberculosis vaccines: advancements and on-going clinical trials
  Emerging Paradigms in Delivery Systems for Antitubercular Therapy 2025 DOI: 10.1016/b978-0-443-24035-5.00015-3
  +Save
• A Double-Blinded Placebo-Controlled Randomized Trial with or without Memantine for the Prevention of Radiation-Induced Cognitive Dysfunction in Brain Metastatic Patients—CTRI/2022/01/039599: An Interim Analysis
  Indian Journal of Medical and Paediatric Oncology 2024 DOI: 10.1055/s-0044-1788206
  +Save
• Audit of Presentation, Primary Site, and Pattern of Treatment in 778 Indian Patients with Brain Metastasis in 15 Years (2007–2022)
  Neurology India 2024 DOI: 10.4103/ni.neurol-india-d-23-00143
  +Save
• Efficacy of memantine in preventing neurocognitive dysfunction induced by radiation therapy in patients with brain metastases: A systematic review of clinical trials
  Seminars in Oncology 2023 DOI: 10.1053/j.seminoncol.2023.09.004
  +Save
• CO104 Efficacy of Memantine in Preventing Neurocognitive Dysfunction Induced By Radiation Therapy in Patients with Brain Metastases: A Systematic Review of Clinical Trials
  Value in Health 2022 DOI: 10.1016/j.jval.2022.04.200
  +Save